Zdrowie i gospodarka · 6.02.2026
FDA Announces Availability of Draft Guidance for Patient Preference Studies
The FDA has released a draft guidance for industry on general considerations for patient preference studies, prepared by the International Council for Harmonisation, aimed at informing drug development and regulatory submissions.